Egyptian Liver Journal

Table 2 Comparison between the two studied groups according to different tumor markers

From: Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients

	Group A (n = 40)	Group B (n = 40)	U	p
AFP (ng/ml)
Min–max	1.0–51.0	1.10–589.0	291.50^*	< 0.001^*
Mean ± SD	8.85 ± 14.51	90.49 ± 132.65
Median	3.85	0.0
OPN (ng/ml)
Min–max	5.10–29.30	6.10–80.40	417.0^*	< 0.001^*
Mean ± SD	11.08 ± 4.20	22.87 ± 19.31
Median	10.30	16.10
ANXA2 (ng/ml)
Min–max	5.40–16.60	8.90–40.80	116.50^*	< 0.001^*
Mean ± SD	8.34 ± 2.34	14.98 ± 5.93
Median	8.05	13.45

U Mann Whitney test
p p value for comparing between the studied groups
^*Statistically significant at p ≤ 0.05

Back to article page